American Hospital Association February 20, 2025
The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid use disorder treatment with buprenorphine continued with it for at least six months in office-based settings. Those who did not continue treatment were more likely to have died for any cause during the study period than those...
Today's Sponsors
Today's Sponsor
Topics: Govt Agencies, Insurance, Medicare, OIG, Patient / Consumer, Provider, Survey / Study, Trends